dibasic sodium phosphate, monobasic potassium phosphate and monobasic sodium phosphate

Generic: dibasic sodium phosphate, monobasic potassium phosphate and monobasic sodium phosphate

Labeler: rising pharma holdings, inc.
NDC Directory HUMAN PRESCRIPTION DRUG UNAPPROVED DRUG OTHER Inactive Finished

Drug Facts

Product Profile

Brand Name dibasic sodium phosphate, monobasic potassium phosphate and monobasic sodium phosphate
Generic Name dibasic sodium phosphate, monobasic potassium phosphate and monobasic sodium phosphate
Labeler rising pharma holdings, inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

potassium phosphate, monobasic 155 mg/1, sodium phosphate, dibasic, anhydrous 852 mg/1, sodium phosphate, monobasic, monohydrate 130 mg/1

Manufacturer
Rising Pharma Holdings, Inc.

Identifiers & Regulatory

Product NDC 64980-104
Product ID 64980-104_95e4295a-3e98-4533-978b-751d6017b33b
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category UNAPPROVED DRUG OTHER
Listing Expiration 2026-12-31
Marketing Start 2012-06-28

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 64980104
Hyphenated Format 64980-104

Supplemental Identifiers

RxCUI
200251
UPC
0364980104012
UNII
4J9FJ0HL51 22ADO53M6F 593YOG76RN

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name dibasic sodium phosphate, monobasic potassium phosphate and monobasic sodium phosphate (source: ndc)
Generic Name dibasic sodium phosphate, monobasic potassium phosphate and monobasic sodium phosphate (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 155 mg/1
  • 852 mg/1
  • 130 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (64980-104-01)
source: ndc

Packages (1)

Ingredients (3)

potassium phosphate, monobasic (155 mg/1) sodium phosphate, dibasic, anhydrous (852 mg/1) sodium phosphate, monobasic, monohydrate (130 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "95e4295a-3e98-4533-978b-751d6017b33b", "openfda": {"upc": ["0364980104012"], "unii": ["4J9FJ0HL51", "22ADO53M6F", "593YOG76RN"], "rxcui": ["200251"], "spl_set_id": ["b01eac95-dbe3-4b21-a922-187e0fc8ad23"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (64980-104-01)", "package_ndc": "64980-104-01", "marketing_start_date": "20120628"}], "brand_name": "Dibasic Sodium Phosphate, Monobasic Potassium Phosphate and Monobasic Sodium Phosphate", "product_id": "64980-104_95e4295a-3e98-4533-978b-751d6017b33b", "dosage_form": "TABLET", "product_ndc": "64980-104", "generic_name": "Dibasic Sodium Phosphate, Monobasic Potassium Phosphate and Monobasic Sodium Phosphate", "labeler_name": "Rising Pharma Holdings, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Dibasic Sodium Phosphate, Monobasic Potassium Phosphate and Monobasic Sodium Phosphate", "active_ingredients": [{"name": "POTASSIUM PHOSPHATE, MONOBASIC", "strength": "155 mg/1"}, {"name": "SODIUM PHOSPHATE, DIBASIC, ANHYDROUS", "strength": "852 mg/1"}, {"name": "SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE", "strength": "130 mg/1"}], "marketing_category": "UNAPPROVED DRUG OTHER", "marketing_start_date": "20120628", "listing_expiration_date": "20261231"}